Orthognathic Surgery (Jaw Surgery): Procedure, Recovery, and Outcomes — Cost, Top Hospitals & Success Rates | MyMedicPlus

Orthognathic surgery — from the Greek orthos (straight) and gnathos (jaw) — is a field of oral and maxillofacial surgery (OMFS) concerned with the surgical correction of skeletal jaw discrepancies that cannot be addressed by orthodontic treatment alone. Unlike purely cosmetic jaw surgery, orthognathic surgery has a primarily functional mandate: correcting the skeletal architecture underlying malocclusion, facial asymmetry, breathing disorders, and temporomandibular joint (TMJ) pathology.

Orthognathic procedures are performed under general anaesthesia, typically during a planned inpatient admission, following a preparatory phase of 12–24 months of pre-surgical orthodontic treatment (dental decompensation). The surgery repositions one or both jaws in three-dimensional space — forward, backward, up, down, rotated, expanded, or any combination — and is stabilised with titanium plates and screws applied through intraoral incisions (no external scars).

Orthognathic surgery is a multidisciplinary endeavour requiring close coordination between the oral and maxillofacial surgeon, the orthodontist, and frequently a speech and language therapist, sleep physician, and clinical psychologist or counsellor. The introduction of three-dimensional virtual surgical planning (VSP) using cone beam CT (CBCT) and digital dental models has transformed precision and predictability — the surgeon can simulate the entire operation digitally, fabricate surgical wafers (splints) in advance, and verify outcomes against the planned movement before the patient leaves the operating room.

Approximately 1–2% of the population in developed countries have a malocclusion of sufficient skeletal severity to warrant orthognathic surgery. The procedure is most commonly performed between the ages of 17–25, after completion of skeletal growth, though older adults are increasingly treated as health and technology standards improve. High-volume specialist units in the UK, USA, Germany, South Korea, and India perform several hundred orthognathic cases per year, with patient satisfaction exceeding 90% in systematic review surveys.

Orthognathic surgery addresses a range of skeletal and functional jaw discrepancies:

• Skeletal Class III malocclusion: Mandibular prognathism (excessive mandibular growth) combined with or without maxillary hypoplasia (underdeveloped upper jaw). The most common presentation in East Asian populations. Causes reverse overjet (underbite), compromised chewing, and concave facial profile. Corrected by maxillary advancement (Le Fort I) with or without mandibular setback (BSSO) — bimaxillary surgery.
• Skeletal Class II malocclusion: Mandibular retrognathia (small or receding chin/jaw), occasionally with maxillary excess. Causes excessive overjet, deep overbite, and convex profile. Corrected by mandibular advancement (BSSO) with or without maxillary superior repositioning (Le Fort I), and/or genioplasty.
• Vertical jaw discrepancies: Long face syndrome (vertical maxillary excess — gummy smile, anterior open bite) treated by maxillary impaction (Le Fort I superior repositioning). Short face syndrome managed by maxillary inferior repositioning with interpositional bone graft.
• Facial asymmetry: Skeletal jaw asymmetry (hemifacial microsomia, condylar hyperplasia or hypoplasia, unilateral growth disturbance) requiring asymmetric repositioning of one or both jaws.
• Obstructive sleep apnoea (OSA): Maxillomandibular advancement (MMA) — simultaneous 10–12 mm forward movement of both jaws — enlarges the pharyngeal airway circumferentially and is the most effective surgical treatment for OSA, achieving 85–90% reduction in apnoea-hypopnoea index (AHI). Indicated for moderate-to-severe OSA refractory to CPAP or mandibular advancement device therapy.
• Cleft lip and palate: Secondary orthognathic surgery (Le Fort I maxillary advancement, occasionally bimaxillary) corrects the midface hypoplasia that results from scarring and growth restriction following primary cleft repair, typically performed in late adolescence or early adulthood.
• TMJ disorders with skeletal component: Total alloplastic TMJ replacement (Biomet/Stryker TMJ Concepts prosthesis) for end-stage TMJ disease, bony ankylosis, failed previous joint surgery, or severe condylar resorption, often combined with concomitant jaw repositioning.
• Severe mandibular hypoplasia: Pierre Robin sequence, hemifacial microsomia — distraction osteogenesis (DO) provides gradual bone elongation via callotasis where single-stage surgery is inadequate.

Patient selection for orthognathic surgery requires comprehensive multidisciplinary assessment encompassing skeletal maturity, dental status, functional and aesthetic goals, and medical fitness for general anaesthesia:

Skeletal Maturity: Surgery requires completion of jaw growth to avoid relapse caused by continued post-operative growth. Minimum ages are conventionally 16–17 for females and 17–18 for males. Skeletal maturity is confirmed by serial lateral cephalometric radiographs demonstrating no measurable change over 6–12 months, and by cervical vertebral maturation (CVM) staging on the lateral cephalogram. In patients with Class III prognathism (the most growth-sensitive group), surgery is sometimes deferred until age 20–22 if mandibular growth persists.

Pre-surgical Orthodontic Preparation: Dental decompensation — alignment of teeth in their correct positions within the dental bases, removing the compensatory tilting that teeth adopt to achieve occlusal contact in the presence of skeletal discrepancy — is mandatory before surgery. This phase requires 12–24 months of fixed orthodontic appliance treatment and is coordinated with the surgeon to achieve the planned pre-operative dental position. The decompensation phase typically transiently worsens the patient's bite before surgery — patients must understand and accept this.

Three-Dimensional Diagnostic Records: Mandatory pre-operative records include cone beam CT (CBCT) of the facial skeleton, digital dental models (from intraoral scan), clinical photographs, and lateral and posterior-anterior cephalometric radiographs. Virtual surgical planning (VSP) software integrates CBCT and dental scans to plan precise jaw movements, simulate outcomes, and fabricate intermediate and final occlusal wafers (splints) for intraoperative guidance.

Medical Fitness: Full pre-anaesthetic assessment, haematological workup, and specialist referral for any significant comorbidities (cardiac, respiratory, haematological). Patients should be non-smoking and at a healthy weight. Adequate bone stock is required for rigid fixation plate and screw placement.

Psychological Readiness: Realistic expectations regarding the recovery timeline (swelling, diet restrictions) and acceptance of the anticipated facial change are assessed. Some centres use validated psychometric tools and clinical psychology consultation for complex cases or patients with dysmorphophobia.

Orthognathic surgery employs several well-established osteotomy techniques, used individually or in combination based on the nature and magnitude of the skeletal discrepancy:

Le Fort I Maxillary Osteotomy: A horizontal cut through the maxilla above the root apices, running from the piriform aperture to the pterygoid plates bilaterally, allowing the entire upper jaw (dento-alveolar maxilla) to be freely repositioned in 6 degrees of freedom — forward, backward, upward (impaction), downward, rotated, or expanded. Superior repositioning (impaction) is the most common movement and consistently stable. Segmental Le Fort I (Bell technique) divides the mobilised maxilla into 2–4 segments for simultaneous dental arch expansion and alignment — used in patients with transverse maxillary deficiency not amenable to palatal expansion alone.

Bilateral Sagittal Split Osteotomy (BSSO): The Obwegeser-Dal Pont technique divides the mandibular ramus and body bilaterally through a sagittal split — the proximal (condyle-bearing) segment remains attached to the TMJ, while the distal (tooth-bearing) segment can be advanced (Class II correction), set back (Class III correction), rotated, or combined with asymmetric movements. Rigid internal fixation uses three bicortical position screws or titanium mini-plates. BSSO is the most commonly performed jaw osteotomy worldwide.

Genioplasty (Sliding Osteotomy of the Chin): A horizontal osteotomy of the symphysis below the inferior alveolar nerve foramina allows the chin segment to be advanced, set back, elevated (reduced), lowered (augmented), or asymmetrically repositioned. Genioplasty is frequently added to BSSO or bimaxillary surgery to optimise lower facial proportion and profile.

Bimaxillary Surgery (Le Fort I + BSSO): Simultaneous repositioning of both jaws in a single operation — the surgical gold standard for complex Class III and Class II skeletal discrepancies with significant maxillary and mandibular components. Intraoperative sequencing uses pre-fabricated VSP wafers to verify intermediate and final occlusal positions accurately.

Maxillomandibular Advancement (MMA) for OSA: Simultaneous 10–12 mm advancement of both maxilla (Le Fort I) and mandible (BSSO) dramatically enlarges the retrolingual and retropalatal airway. The most effective surgical treatment for OSA — systematic review and meta-analysis data (Holty and Guilleminault, 2010) report 86% mean AHI reduction and treatment success rate (>50% AHI reduction) exceeding 85–90%.

Distraction Osteogenesis (DO): For severe mandibular hypoplasia (Pierre Robin sequence, hemifacial microsomia) where the degree of deficiency is too great for single-stage surgery, a corticotomy is made and a distracting device gradually separates the bone segments at 1 mm per day. New bone (callotasis) fills the distraction gap. Avoids the need for large interpositional bone grafts and enables movement exceeding 15–20 mm.

Total Alloplastic TMJ Replacement: Biomet (Lorenz/Walter Lorenz Surgical) or Stryker (KLS Martin) prosthetic TMJ systems (fossa component + condylar prosthesis) replace end-stage, ankylosed, or previously failed TMJ anatomy. Often combined with concomitant jaw osteotomies to simultaneously correct the associated skeletal deformity.

Orthognathic surgery offers profound and durable functional, health, aesthetic, and quality-of-life benefits for appropriately selected patients:

• Correction of jaw function: Improved masticatory (chewing) efficiency and comfort, normalisation of bite force distribution, correction of aberrant swallowing patterns, and resolution of occlusal interferences and tooth wear associated with malocclusion are consistent outcomes of successful orthognathic surgery.
• Obstructive sleep apnoea cure: MMA is the most effective permanent surgical treatment for OSA, achieving 85–90% reduction in AHI in systematic reviews — superior to uvulopalatopharyngoplasty (UPPP) and other soft palate procedures. Unlike CPAP (effective only when worn), MMA provides continuous structural airway enlargement.
• Facial aesthetics and profile improvement: Orthognathic surgery corrects the underlying facial skeleton, achieving natural and harmonious facial proportions that cannot be replicated by soft tissue fillers or implants. Systematic reviews report high levels of patient satisfaction (>85–90%) with facial aesthetic outcomes, often sustained at long-term follow-up.
• Psychological and psychosocial benefit: Multiple prospective studies demonstrate significant improvements in self-esteem, body image, social interaction, and dental and oral health-related quality of life (OHQoL) following orthognathic surgery. The Orthognathic Quality of Life Questionnaire (OQLQ) is a validated instrument documenting this improvement.
• Long-term dental health: Normalisation of occlusal contacts reduces destructive loading on teeth and supporting structures, decreasing the long-term risk of enamel attrition, tooth fracture, and periodontal bone loss from traumatic occlusion.
• Speech improvement: Class III skeletal correction and open bite closure improve articulation of lingual-dental consonants. Velopharyngeal function may improve after maxillary advancement in cleft-related cases.
• Stability: Modern rigid fixation techniques with titanium plates and screws, combined with meticulous VSP-guided intraoperative precision, have dramatically improved surgical stability — Le Fort I maxillary advancement is among the most stable orthognathic movements with relapse rates below 1–3%.

Orthognathic surgery is a major elective procedure performed under general anaesthesia, with well-characterised risks that must be discussed in detail during informed consent:

Neurosensory Disturbance (most significant complication):

• Inferior alveolar nerve (IAN) injury: The IAN runs within the mandibular canal and is at risk during BSSO. Transient IAN hypoaesthesia (altered sensation of the lower lip, chin, and gingiva) occurs in 30–50% of BSSO patients. The majority (70–80%) recover to normal sensation within 6–12 months. Permanent hypoaesthesia or paraesthesia — affecting 5–10% — is more common with mandibular setback (Class III correction) than advancement, as the nerve is subjected to greater stretching and compression. Formal neurosensory testing using 2-point discrimination and Semmes-Weinstein monofilaments tracks recovery.
• Mental nerve and lingual nerve: At lower risk but may be affected in genioplasty (mental nerve) or BSSO (lingual nerve — transient lingual numbness in approximately 5%).

Surgical and Anaesthetic Risks:

• Blood loss: Average intraoperative blood loss is 200–500 ml for bimaxillary surgery; transfusion requirement is rare at experienced centres using hypotensive anaesthesia and cell salvage. Preoperative autologous blood donation is increasingly rare with modern blood-sparing techniques.
• Airway management: Nasotracheal intubation is required; immediate post-operative airway oedema is managed in a monitored environment with analgesia and anti-emetics.
• Hardware complications: Plate or screw removal is required in fewer than 5% of cases due to hardware palpability, infection, or mucosal breakdown. Plates are titanium and do not require routine removal.
• Infection: Post-operative infection (osteomyelitis, wound dehiscence) occurs in 1–3%. Perioperative antibiotics, chlorhexidine mouthwash, and meticulous wound closure minimise risk.

Skeletal Complications:

• Relapse: The most feared mechanical complication. Le Fort I advancement is very stable (relapse 1–3%). Mandibular advancement BSSO is generally stable (3–5% relapse) with modern rigid fixation. Mandibular setback and bimaxillary surgery with large movements carry higher relapse risk, mitigated by appropriate orthodontic retention and post-surgical exercises.
• Condylar resorption (idiopathic condylar resorption, ICR): Progressive resorption of the mandibular condyles post-operatively, predominantly affecting young women with high mandibular plane angle, antegonial notching, and Class II skeletal morphology. Incidence 1–5%; can lead to Class II relapse and open bite recurrence. Managed by close monitoring, orthodontic compensation, or ultimately total TMJ replacement.
• Unfavourable osteotomy: Bad split — an unfavourable fracture pattern during BSSO (occurring in 1–3%) — may require plate fixation and can prolong recovery.

Recovery from orthognathic surgery follows a structured timeline, with the majority of functional recovery occurring within 6–8 weeks and aesthetic refinement continuing for up to 12 months:

Immediate post-operative period (Days 1–7): Patients are typically managed on the ward for 3–5 nights following bimaxillary surgery (1–2 nights for single-jaw procedures). Airway, haemorrhage, pain, nausea, and fluid balance are prioritised. Guiding elastics (light rubber bands attached between upper and lower brackets) may be placed to guide initial occlusal settling. Intermaxillary fixation (wiring the jaws shut) is now very rarely used; most surgeons use only light guiding elastics. Facial oedema peaks at 48–72 hours and reduces substantially by 2 weeks.

Dietary Progression:

• Days 1–7: Liquid diet only (soups, smoothies, protein shakes).
• Weeks 2–4: Pureed and mushy foods (yoghurt, mashed potato, scrambled eggs).
• Weeks 4–6: Soft diet (pasta, fish, soft vegetables).
• 6 weeks onward: Progressive return to normal diet. Hard, crunchy foods (crusty bread, raw vegetables) reintroduced by 8–10 weeks.

Post-surgical Orthodontics: Orthodontic treatment resumes 4–6 weeks post-operatively once initial bone healing is established and guiding elastics are no longer needed. Post-surgical orthodontic treatment (6–12 months) finalises the dental intercuspation, closes any residual spaces, and achieves the final occlusal contacts planned in VSP. Detailed detailing of root torques and individual tooth positions completes the orthodontic outcome before appliance removal and retention.

Follow-up Schedule: Weekly for the first month; monthly for months 2–6; then every 3 months until 12–18 months post-surgery. Lateral cephalometric radiographs at 6 weeks, 3 months, and 12 months assess skeletal stability and any condylar resorption. Neurosensory testing is performed at each visit to track IAN recovery.

Swelling Resolution: Approximately 60–70% of swelling resolves by 3 weeks, 80% by 6 weeks, and 100% by 9–12 months. Patients should be counselled that final aesthetic outcome assessment should be deferred until at least 12 months post-surgery.

Orthognathic surgery cost is determined by the complexity of the planned procedure, the need for VSP technology and laboratory-fabricated wafers, the duration of pre- and post-surgical orthodontics, and the country and healthcare system in which treatment is delivered.

NHS Funding (United Kingdom): Orthognathic surgery is available on the NHS for patients meeting IOTN (Index of Orthodontic Treatment Need) and SCAN (Scottish Intercollegiate Guidelines Network) criteria — generally for patients with significant functional impairment, not for purely aesthetic indication. NHS waiting times at dedicated tertiary OMFS units range from 18–36 months for surgery. NHS coverage includes all pre-surgical orthodontics, surgery, hospitalisation, post-surgical orthodontics, and follow-up.

Private UK Costs (approximate):

• Pre-surgical orthodontics: GBP 3,000–6,000 (18–24 months, fixed appliances).
• Single jaw surgery (Le Fort I or BSSO): GBP 10,000–18,000.
• Bimaxillary surgery (Le Fort I + BSSO): GBP 15,000–25,000.
• Bimaxillary + genioplasty: GBP 18,000–28,000.
• Virtual surgical planning: GBP 1,500–3,000 additional.
• Post-surgical orthodontics: GBP 2,500–5,000.

USA Costs: USD 20,000–60,000 for surgery alone, depending on procedure complexity and provider. Total treatment cost including orthodontics: USD 30,000–80,000. Insurance coverage varies; functional indications (OSA, chewing difficulty) may be partially covered.

Medical Tourism:

• India (AIIMS, Apollo, CMC Vellore): USD 5,000–12,000 for bimaxillary surgery at top-tier academic units. Growing international referral base, particularly from the Middle East and South Asia.
• South Korea: Highly developed orthognathic surgery market; USD 15,000–30,000 at premium aesthetic surgery clinics in Seoul. Very high case volume with experienced surgical teams.
• Thailand: USD 8,000–18,000 at Bangkok and Chiang Mai private hospitals.
• Hungary: EUR 8,000–16,000; well-established for European patients seeking cost savings.

For patients who decline surgery, cannot undergo general anaesthesia, or whose skeletal discrepancy falls within the threshold amenable to non-surgical management, the following alternatives are available — with important limitations:

• Orthodontic camouflage: Fixed orthodontic appliances can compensate for mild-to-moderate skeletal discrepancies by tilting and moving teeth to achieve an acceptable occlusal relationship despite underlying jaw discrepancy. For example, in a mild Class III case, upper teeth can be proclined and lower teeth retroclined to produce acceptable overjet and overbite. Camouflage is limited by the degree of skeletal discrepancy — BSSO setbacks exceeding 6–8 mm, Le Fort I advancements exceeding 6 mm, and severe open bite or asymmetry are not amenable to camouflage alone without surgical correction. Camouflage also cannot fully address the facial profile or functional deficits.
• Mandibular advancement device (MAD) for OSA: Custom titratable intraoral devices advance the mandible during sleep, reducing upper airway collapsibility. Effective for mild-to-moderate OSA and for patients who decline or cannot tolerate CPAP or MMA. Less effective than MMA for severe OSA or patients with significant skeletal retrognathia.
• CPAP therapy for OSA: Continuous positive airway pressure remains the gold standard non-surgical treatment for moderate-to-severe OSA but requires nightly device use and provides no structural correction. Patient adherence rates are approximately 60–70% at 12 months.
• Facial implants (alloplastic augmentation): Chin implants (alloplastic subperiosteal prostheses) can augment chin projection cosmetically but do not correct the underlying skeletal jaw discrepancy, improve occlusion, or provide functional benefits. Cannot treat Class II or III malocclusion.
• Distraction osteogenesis as staged alternative: In patients with very severe discrepancies, distraction osteogenesis (gradual bone elongation with a distraction device, 1 mm/day) avoids the need for large grafts and reduces neurovascular injury risk compared with single-stage large osteotomies.
• Conservative management: In older patients with mild functional impairment and completed growth, watchful waiting with symptomatic management (diet modification, physiotherapy for TMJ symptoms, sleep positioning for mild OSA) may be appropriate after a fully informed decision-making discussion.